7-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98+%, 5g

Ethyl 2-(benzyloxy)acetate, 95.0%, 100g

2-Chloro-5H-pyrrolo[3,2-d]pyrimidine-4-carboxylic acid, 98%, 10g

8-Ethynyl-1,4-dioxaspiro[4.5]decane, 98%, 10g

Tris(4-(4H-1,2,4-triazol-4-yl)phenyl)amine, 97%, 5g

Fmoc-allo-Thr(tBu)-OH, 95.0%, 5g

3-[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]CYCLOBUTANOL, 95.0%, 100mg

4,4,5,5-Tetramethyl-2-(2,3,5,6-tetrafluorophenyl)-1,3,2-dioxaborolane, 97.0%, 1g

5-Methyl-3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazole, 5g

Benzyl (R)-2-(hydroxymethyl)piperazine-1-carboxylate (hydrochloride), 250mg

Sodium hydroxide, min. 99%, 10 kg, plastic packaging.

2-Methoxy-4-(trifluoromethyl)benzyl alcohol, 5g

Pyrimidine-4-carbohydrazide, 95.0%, 250mg